EPCAM and breast carcinoma: As the CellSearch test is based on the expression of epithelial cell adhesion molecule (EpCAM) on CTCs and with EpCAM demonstrated to be downregulated in most aggressive breast cancer cells undergoing epithelial-to-mesenchymal transition (EMT), the ability of the test to accurately detect disease even in advanced stages might be limited (140, 141).